Metlife (NYSE:MET) posted its earnings results on Wednesday. The financial services provider reported $1.38 earnings per share for the quarter, topping analysts’ consensus estimates of $1.31 by $0.07, Briefing.com reports. Metlife had a net margin of 7.56% and a return on equity of 10.20%. The firm had revenue of $16.45 billion for the quarter, compared to the consensus estimate of $16.43 billion. During the same period in the previous year, the firm posted $1.30 EPS. The business’s quarterly revenue was down 22.4% on a year-over-year basis.
Metlife stock traded down $1.04 during trading hours on Friday, hitting $47.29. The company had a trading volume of 8,805,928 shares, compared to its average volume of 3,286,178. The company has a market cap of $45.42 billion, a price-to-earnings ratio of 8.77, a P/E/G ratio of 1.08 and a beta of 1.10. The company has a debt-to-equity ratio of 0.24, a quick ratio of 0.14 and a current ratio of 0.14. Metlife has a 1 year low of $37.76 and a 1 year high of $51.16. The business’s 50-day simple moving average is $49.77.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, September 13th. Shareholders of record on Tuesday, August 6th will be given a $0.44 dividend. The ex-dividend date of this dividend is Monday, August 5th. This represents a $1.76 annualized dividend and a yield of 3.72%. Metlife’s dividend payout ratio (DPR) is 32.65%.
A number of research firms have recently weighed in on MET. Citigroup set a $42.00 target price on shares of Metlife and gave the stock a “sell” rating in a report on Thursday, May 23rd. UBS Group boosted their target price on shares of Metlife from $45.00 to $48.00 and gave the stock a “neutral” rating in a report on Tuesday, April 9th. Morgan Stanley boosted their target price on shares of Metlife from $52.00 to $53.00 and gave the stock an “equal weight” rating in a report on Wednesday, July 10th. Zacks Investment Research raised shares of Metlife from a “sell” rating to a “hold” rating and set a $51.00 price target for the company in a research note on Friday. Finally, Deutsche Bank lifted their price target on shares of Metlife from $46.00 to $47.00 and gave the stock a “hold” rating in a research note on Friday, April 12th. Two research analysts have rated the stock with a sell rating, five have issued a hold rating and six have given a buy rating to the company’s stock. The company has an average rating of “Hold” and an average target price of $50.91.
Metlife Company Profile
MetLife, Inc engages in the insurance, annuities, employee benefits, and asset management businesses. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short- and long-term disability, individual disability, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and stable value products, including general and separate account guaranteed interest contracts, and private floating rate funding agreements.
Read More: How to Invest in Growth Stocks
Receive News & Ratings for Metlife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Metlife and related companies with MarketBeat.com's FREE daily email newsletter.